Add like
Add dislike
Add to saved papers

Outpatient mean arterial pressure: A potentially modifiable risk for acute kidney injury and death among cirrhosis patients.

Liver Transplantation 2024 March 28
BACKGROUND: Mean arterial blood pressure (MAP), which decreases as portal hypertension progresses, may be a modifiable risk factor among cirrhosis patients.

METHODS: We included adults enrolled in the FrAILT study. We completed latent class trajectory analyses (LCTA) to define MAP trajectories. We completed time-dependent Cox-regression analyses to test the association between outpatient MAP and 3 cirrhosis-related outcomes: 1) Stage 2 acute kidney injury (AKI), defined as a ≥200% increase in serum creatinine from baseline; 2) a 5-point increase in the MELDNa score, defined as the incidence of increase from initial MELDNa; 3) waitlist mortality (WLM), defined as death on the WL. For each outcome, we defined MAP cutpoints by determining the maximally selected Log-rank statistic after univariable Cox-regression analyses.

RESULTS: Among the 1,786 patients included in this analysis, our LCTA identified 3-specific outpatient MAP trajectories: "stable-low", "stable-high", and "increasing-to-decreasing". However, >80% of patients were in a "stable-low" trajectory. We found in adjusted analyses that outpatient MAP was associated with each of our outcomes: Stage 2 AKI (adjusted hazard ratio [aHR]0.88 per 10 mmHg increase in MAP[95CI 0.79-0.99]); 5-point increase in MELDNa (aHR0.91[95CI 0.86-0.96]; WLM (aHR0.89[95CI 0.81-0.96]). For each outcome, we found that an outpatient MAP of 82 mmHg was most associated with outcomes (p<0.05 for all).

DISCUSSION: Our study informs the association between outpatient MAP and cirrhosis-related outcomes. These findings, coupled with the identification of specific thresholds, lays the foundation for the trial of targeted outpatient MAP modulation in cirrhosis patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app